These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

109 related articles for article (PubMed ID: 4042862)

  • 21. [Hematological toxicity of ticlopidine? (author's transl)].
    de Gramont A; Canuel C; Krulik M; Bauters F; Degos L; Marty M; Najean Y
    Nouv Rev Fr Hematol (1978); 1982; 24(1):35-7. PubMed ID: 7071010
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Clinical implications of very low on-treatment platelet reactivity in patients treated with thienopyridine: the POBA study (predictor of bleedings with antiplatelet drugs).
    Cuisset T; Grosdidier C; Loundou AD; Quilici J; Loosveld M; Camoin L; Pankert M; Beguin S; Lambert M; Morange PE; Bonnet JL; Alessi MC
    JACC Cardiovasc Interv; 2013 Aug; 6(8):854-63. PubMed ID: 23968703
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Platelet inhibitors versus anticoagulants for prevention of aorto-coronary bypass graft occlusion.
    Rothlin ME; Pfluger N; Speiser K; Goebel N; Krayenbühl HP; Steinbrunn W; Turina M; Senning A
    Eur Heart J; 1985 Feb; 6(2):168-75. PubMed ID: 3891348
    [TBL] [Abstract][Full Text] [Related]  

  • 24. [Ticlopidine: blood and liver involvement?].
    Biour M; Toussaint P; Duhamel G; Canuel C; Krulick M; Calmus Y
    Therapie; 1982; 37(2):222-4. PubMed ID: 7112492
    [No Abstract]   [Full Text] [Related]  

  • 25. Effects of high ticlopidine doses on platelet function in acute coronary syndrome patients.
    Bélanger P; Palisaitis DA; Diodati JG; Pharand C
    J Cardiovasc Pharmacol; 2004 Jan; 43(1):128-32. PubMed ID: 14668578
    [TBL] [Abstract][Full Text] [Related]  

  • 26. The effect of Ticlopidine upon platelet function, haemorrhage and post-operative thrombosis in patients undergoing suprapubic prostatectomy.
    Brommer EJ
    J Int Med Res; 1981; 9(3):203-10. PubMed ID: 7238995
    [TBL] [Abstract][Full Text] [Related]  

  • 27. [Thrombocytopenia due to antibodies induced by ticlopidine].
    Claas FH; de Fraiture WH; Meyboom RH
    Nouv Rev Fr Hematol (1978); 1984; 26(5):323-4. PubMed ID: 6504695
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Antiplatelet effects of clopidogrel and bleeding in patients undergoing coronary stent placement.
    Sibbing D; Schulz S; Braun S; Morath T; Stegherr J; Mehilli J; Schömig A; von Beckerath N; Kastrati A
    J Thromb Haemost; 2010 Feb; 8(2):250-6. PubMed ID: 19943882
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Effect of clopidogrel premedication in off-pump cardiac surgery: are we forfeiting the benefits of reduced hemorrhagic sequelae?
    Kapetanakis EI; Medlam DA; Petro KR; Haile E; Hill PC; Dullum MK; Bafi AS; Boyce SW; Corso PJ
    Circulation; 2006 Apr; 113(13):1667-74. PubMed ID: 16567570
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Prasugrel for acute coronary syndromes: faster, more potent, but higher bleeding risk.
    Lazar LD; Lincoff AM
    Cleve Clin J Med; 2009 Dec; 76(12):707-14. PubMed ID: 19952295
    [TBL] [Abstract][Full Text] [Related]  

  • 31. The influence of ticlopidine on the natural course of retinal vein occlusion.
    Houtsmuller AJ; Vermeulen JA; Klompe M; Zahn KJ; Henkes HE; Baarsma GS; Tijssen J
    Agents Actions Suppl; 1984; 15():219-29. PubMed ID: 6385648
    [TBL] [Abstract][Full Text] [Related]  

  • 32. [Ticlopidine in heart surgery with cardiopulmonary by-pass (author's transl)].
    Renner C; Guilmet D; Curtet JM
    Nouv Presse Med; 1980 Nov; 9(43):3249-51. PubMed ID: 7454568
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Ischaemia versus bleeding: the art of clinical decision-making.
    Stone GW
    Lancet; 2009 Feb; 373(9665):695-6. PubMed ID: 19249613
    [No Abstract]   [Full Text] [Related]  

  • 34. Study of platelet aggregation induced by platelet activating factor (PAF) after administration of ticlopidine or aspirin.
    Lecrubier C; Conard J; Horellou MH; Samama M
    Agents Actions; 1983 Feb; 13(1):77-80. PubMed ID: 6858789
    [TBL] [Abstract][Full Text] [Related]  

  • 35. New anti-platelet agents: the end of resistance?
    Kastrati A
    Thromb Res; 2012 Oct; 130 Suppl 1():S53-5. PubMed ID: 23026663
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Bleeding risks with prasugrel in the TRITON trial: good news ... bad news.
    Serebruany VL
    Cardiology; 2008; 111(4):265-7. PubMed ID: 18434736
    [No Abstract]   [Full Text] [Related]  

  • 37. Clopidogrel administration prior to coronary artery bypass grafting surgery: the cardiologist's panacea or the surgeon's headache?
    Kapetanakis EI; Medlam DA; Boyce SW; Haile E; Hill PC; Dullum MK; Bafi AS; Petro KR; Corso PJ
    Eur Heart J; 2005 Mar; 26(6):576-83. PubMed ID: 15723815
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Antiaggregatory, physiological and clinical effects of ticlopidine in subjects with peripheral atherosclerosis.
    Kirstein P; Jogestrand T; Johnsson H; Olsson AG
    Atherosclerosis; 1980 Aug; 36(4):471-80. PubMed ID: 7417366
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Evaluation of antiplatelet effects of a modified protocol by platelet aggregation in patients undergoing "one-stop" hybrid coronary revascularization.
    Gao P; Xiong H; Zheng Z; Li L; Gao R; Hu SS
    Platelets; 2010; 21(3):183-90. PubMed ID: 20201634
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Platelet aggregation measured in rabbit whole blood: in vitro study of 3 aggregating agents and ex vivo inhibition by aspirin and ticlopidine.
    Chevolet C; Grosdent JC; Reiters GM; Dresse A
    Arch Int Pharmacodyn Ther; 1982 Oct; 259(2):310-1. PubMed ID: 6817725
    [No Abstract]   [Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 6.